Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 17-Jun-24 4:15 PM View:  | Mereo Biopharma Group Plc (MREO) | 17-Jun-24 | Grant | 25,050 | $3.99 | $99,949.50 | 100% 0 to 25.05K | |
| 11-Jun-24 4:12 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 10-Jun-24 | Grant | 45,000 | -- | -- | 59% 76.67K to 121.67K | |
| 22-Aug-23 4:09 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 18-Aug-23 | Private Purchase | 25,000 | $1.20 | $29,875.00 | 48% 51.67K to 76.67K | |
| 14-Jun-23 4:59 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 13-Jun-23 | Grant | 45,000 | -- | -- | 675% 6.67K to 51.67K | |
| 17-Nov-22 9:11 PM View: | Logicbio Therapeutics, Inc. (LOGC) | 16-Nov-22 | Disposition | 3,141 | -- | -- | (100%) 3.14K to 0 | |
| 27-Jun-22 4:16 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 06-Jun-22 | Grant | 6,667 | -- | -- | 100% 0 to 6.67K | |
| 02-Mar-21 7:00 PM View: | EXACT Sciences Corp. (EXAS) | 26-Feb-21 | Option Exercise | 10,108 | $26.98 | $272,714.00 | 88% 11.47K to 21.58K | |
| 02-Mar-21 7:00 PM View: | EXACT Sciences Corp. (EXAS) | 26-Feb-21 | Market Option Sale (Planned) | 10,108 | $130.11 | $1,315,150.00 | (47%) 21.58K to 11.47K | 15% |
| 02-Mar-21 7:00 PM View: | EXACT Sciences Corp. (EXAS) | 26-Feb-21 | Market Sale (Planned) | 8,913 | $130.11 | $1,159,670.00 | (78%) 11.47K to 2.56K | 15% |
| 04-Jan-21 7:00 PM View: | Logicbio Therapeutics, Inc. (LOGC) | 01-Jan-21 | Option Exercise | 3,141 | -- | -- | 100% 0 to 3.14K | |
| 24-Jul-20 4:36 PM View: | EXACT Sciences Corp. (EXAS) | 23-Jul-20 | Grant | 2,558 | -- | -- | 29% 8.91K to 11.47K | |
| 02-Aug-19 4:25 PM View: | EXACT Sciences Corp. (EXAS) | 31-Jul-19 | Option Exercise | 2,500 | $26.98 | $67,450.00 | 22% 11.41K to 13.91K | |
| 02-Aug-19 4:25 PM View: | EXACT Sciences Corp. (EXAS) | 31-Jul-19 | Market Option Sale (Planned) | 2,500 | $117.93 | $294,825.00 | (18%) 13.91K to 11.41K | 6% |
| 02-Aug-19 4:25 PM View: | EXACT Sciences Corp. (EXAS) | 31-Jul-19 | Market Sale (Planned) | 2,500 | $117.93 | $294,825.00 | (22%) 11.41K to 8.91K | 6% |
| 26-Jul-19 5:01 PM View: | EXACT Sciences Corp. (EXAS) | 25-Jul-19 | Grant | 2,801 | -- | -- | 33% 8.61K to 11.41K | |
| 01-Mar-19 5:34 PM View: | EXACT Sciences Corp. (EXAS) | 28-Feb-19 | Market Sale (Planned) | 500 | $96.00 | $48,000.00 | (5%) 9.11K to 8.61K | (16%) |
| 30-Aug-18 5:26 PM View: | EXACT Sciences Corp. (EXAS) | 28-Aug-18 | Market Sale (Planned) | 2,468 | $74.85 | $184,730.00 | (21%) 11.58K to 9.11K | (49%) |
| 30-Jul-18 7:46 PM View: | EXACT Sciences Corp. (EXAS) | 26-Jul-18 | Grant | 606 | -- | -- | 6% 10.97K to 11.58K | |
| 11-May-18 4:48 PM View: | EXACT Sciences Corp. (EXAS) | 10-May-18 | Market Sale (Planned) | 7,402 | $51.53 | $381,447.00 | (40%) 18.38K to 10.97K | (116%) |
| 31-Jul-17 5:25 PM View: | EXACT Sciences Corp. (EXAS) | 27-Jul-17 | Grant | 791 | -- | -- | 4% 17.59K to 18.38K | |
| 01-Aug-16 4:45 PM View: | EXACT Sciences Corp. (EXAS) | 28-Jul-16 | Grant | 11,547 | -- | -- | 191% 6.04K to 17.59K | |
| 27-Jul-15 5:12 PM View: | EXACT Sciences Corp. (EXAS) | 23-Jul-15 | Grant | 6,038 | -- | -- | 100% 0 to 6.04K | |
| 27-Mar-14 4:01 PM View: | Akebia Therapeutics, Inc. (AKBA) | 25-Mar-14 | Purchase | 1,500 | $17.00 | $25,500.00 | 100% 0 to 1.5K | |
| 06-Apr-11 11:49 AM View: | Genzyme Corp. (GENZ) | 04-Apr-11 | Disposition | 29,250 | $74.00 | $2,164,500.00 | (51%) 57.35K to 28.11K | (3%) |
| 06-Apr-11 11:49 AM View: | Genzyme Corp. (GENZ) | 04-Apr-11 | Option Exercise | 29,250 | -- | -- | 104% 28.11K to 57.35K | |
| 06-Apr-11 11:49 AM View: | Genzyme Corp. (GENZ) | 04-Apr-11 | Disposition (change in control) | 24,475 | $74.00 | $1,811,150.00 | (87%) 28.11K to 3.63K | (3%) |
| 06-Apr-11 11:49 AM View: | Genzyme Corp. (GENZ) | 04-Apr-11 | Disposition (change in control) | 3,630 | $74.00 | $268,620.00 | (100%) 3.63K to 0 | (3%) |
| 26-May-10 3:43 PM View: | Genzyme Corp. (GENZ) | 25-May-10 | Market Option Sale | 5,068 | $45.63 | $231,253.00 | (16%) 32.63K to 27.56K | (12%) |
| 26-May-10 3:43 PM View: | Genzyme Corp. (GENZ) | 24-May-10 | Option Exercise | 15,000 | -- | -- | 85% 17.63K to 32.63K | |
| 13-Aug-08 12:34 PM View: | Genzyme Corp. (GENZ) | 12-Aug-08 | Option Exercise | 29,390 | $32.57 | $957,254.00 | 178% 16.51K to 45.9K | 142% |
| 13-Aug-08 12:34 PM View: | Genzyme Corp. (GENZ) | 12-Aug-08 | Market Option Sale | 29,390 | $79.00 | $2,321,810.00 | (64%) 45.9K to 16.51K | 33% |
| 18-Dec-07 11:50 AM View: | Genzyme Corp. (GENZ) | 17-Dec-07 | Option Exercise | 5,140 | $23.22 | $119,352.00 | 31% 16.42K to 21.56K | |
| 18-Dec-07 11:50 AM View: | Genzyme Corp. (GENZ) | 17-Dec-07 | Market Option Sale | 5,140 | $74.89 | $384,935.00 | (24%) 21.56K to 16.42K | 30% |
| 22-Jul-05 9:46 AM View: | Genzyme Corp. (GENZ) | 20-Jul-05 | Option Exercise | 63,876 | $32.52 | $2,077,250.00 | 416% 15.37K to 79.25K | |
| 22-Jul-05 9:46 AM View: | Genzyme Corp. (GENZ) | 20-Jul-05 | Market Option Sale | 63,876 | $71.19 | $4,547,330.00 | (81%) 79.25K to 15.37K | 26% |
| 19-Jul-05 9:59 AM View: | Genzyme Corp. (GENZ) | 15-Jul-05 | Option Exercise | 45,488 | $50.22 | $2,284,230.00 | 284% 16.04K to 61.52K | (5%) |
| 19-Jul-05 9:59 AM View: | Genzyme Corp. (GENZ) | 15-Jul-05 | Market Option Sale | 46,152 | $68.94 | $3,181,720.00 | (75%) 61.52K to 15.37K | 24% |
| 19-Jul-05 9:59 AM View: | Genzyme Corp. (GENZ) | 08-Jul-05 | Option Exercise | 664 | $41.50 | $27,556.00 | 4% 15.37K to 16.04K |